MedTrace Logo

Multicenter Mpact DM France

NCT05818891 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-09-29

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty.

The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Conditions

  • Total Hip Arthroplasty
  • Survival, Prosthesis

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Philippe DEROCHE · Centre Orthopédique Médico-Chirurgical de Dracy Le Fort

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-05
Primary Completion
2028-04-30
Completion
2031-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05818891 on ClinicalTrials.gov